Reliance Retail buys 60% of NetMeds parent Vitalic Health for ₹620 crore
Reliance Retail acquired a 60% equity stake in NetMeds parent Vitalic Health for ₹620 crore, marking its entry into e-pharmacy to challenge Amazon and PharmEasy. It plans to raise ownership to 100% by 2024 amid regulatory uncertainty, despite NetMeds posting an FY20 net loss of ₹164.15 crore.
What happened
Reliance Retail acquired a 60% stake in NetMeds parent Vitalic Health for ₹620 crore, entering e-pharmacy to rival Amazon, with plans to raise ownership to 100%
Key facts
- 60% equity stake
- ₹620 crore
- 20% stake by 2024
- FY20 net loss ₹184.3 crore
- NetMeds net loss ₹164.15 crore
- 19.59% ownership
Why this matters
The staged 60%-to-100%-by-2024 structure limits upfront risk amid e-pharmacy regulatory uncertainty while locking in a clear path to full control—a template worth watching for future digital acquisitions.
What to watch
- Central e-pharmacy regulation / Drugs Rules amendments
- Tata-1mg and PharmEasy funding or M&A responses
- Reliance moves toward the remaining 40% stake before 2024
- NetMeds order volume and loss trajectory in subsequent filings
- Amazon India pharmacy expansion beyond initial cities
- Bundle NetMeds fulfillment into JioMart and WhatsApp ordering
- Expand cold-chain and last-mile via Reliance Retail store network as micro-fulfillment nodes
- Aggressive discounting to grab share from PharmEasy and Amazon Pharmacy
- Lobby for favorable e-pharmacy framework alongside diagnostics/teleconsult add-ons